NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

National Bacterial Meningitis Study in Children and Newborns

RecruitingN/A

Sponsor: Association Clinique Thérapeutique Infantile du val de Marne

Conditions: Meningitis, Children, Only, Pneumococcal Conjugate Vaccine, Meningococcal Vaccines, H. Influenzae Vaccine

Countries: France

Bacterial meningitis is a major cause of morbidity and mortality in childhood. Antibiotic treatment recommendations are based on epidemiological and susceptibility data. The epidemiology of bacterialméningitis has changed in recent years, mainly owing to widespread use of different conjugate vaccines. The aim of this prospective national survey is to describe epidemiology of bacteria implicated in bacterial meningitis in children.

Eligibility overview

Sex: ALL

Age: 1 Day to 18 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* clinical signs of meningitis, associated with positive cerebrospinal fluid (CSF) culture and/or positive CSF antigen testing (Escherichia coli K1, N. meningitidis serogroups B, A, C, Y and W-135, group B streptococci, Hib, or S. pneumoniae), and/or positive CSF polymerase chain reaction (PCR), and/or positive blood culture with CSF pleocytosis (\> 10 cells/µL).
* purpura fulminans

Exclusion Criteria:

\-

Locations (1)

Créteil, France